Business Context and Reporting Period
This Form 6-K filing by James Hardie Industries N.V. (now James Hardie Industries Plc) was submitted to the SEC on November 17, 2004. The filing serves to distribute an announcement originally filed with the Australian Stock Exchange on November 16, 2004, regarding interim support provided to the MRCF (Mesothelioma Research and Compensation Fund).
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document is a procedural filing referencing an external announcement rather than a financial report containing quantitative performance data.
Material Changes
No material changes to financial performance or operational metrics are detailed in this specific filing text. The primary event reported is the provision of interim support to the MRCF.
Guidance, Outlook, and Risks
Management Commentary: The filing includes a Safe Harbor Statement regarding forward-looking statements, noting that actual results may differ due to various factors.
Risks and Contingencies: The document explicitly lists several risk factors that could materially affect future results, including:
- Competition and product pricing.
- General economic and market conditions.
- Compliance with environmental and health and safety laws.
- Dependence on senior management and R&D success.
- Supply and cost of raw materials.
- Reliance on a small number of product distributors.
- Consequences of product failures or defects.
- Exposure to environmental, asbestos, or other legal proceedings.
- International business risks, tax law changes, and foreign exchange risks.
Investor Verification Checklist
- Verify the specific amount and terms of the "interim support" provided to the MRCF by reviewing the full text of Exhibit 99.1.
- Confirm the impact of this support on the company's current liquidity and cash reserves.
- Review the company's most recent Form 20-F for detailed financial statements, as this 6-K does not contain them.
- Assess the status of ongoing asbestos-related legal proceedings mentioned in the risk factors.